Trials / Active Not Recruiting
Active Not RecruitingNCT05199948
Weight, Energy, Lipids, and the Liver (WELL) Study
Weight, Energy, Lipids, and the Liver (WELL) Study: Dietary Fat Quality and Ectopic Lipids in the Liver
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (estimated)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 22 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The research study is a parallel arm, randomized placebo-controlled clinical trial designed to assess changes in hepatic lipid accumulation, visceral adipose tissue and postprandial lipid, markers of inflammation and energy metabolism in participants who consume 3 study foods per day for 16 week, while maintaining their body weight.
Detailed description
The study objectives include: 1. To determine the impact of dietary soybean oil on ectopic liver fat and visceral adipose in adults with nonalcoholic fatty liver disease (NAFLD) or similar diagnosis 2. To evaluate the effect of soybean oil supplementation on postprandial lipids, markers of inflammation and energy metabolism 3. To measure the strength of the association of change in plasma linoleic acid with changes in ectopic liver fat, visceral adipose, and postprandial lipids, markers of inflammation and energy metabolism 4. To explore emerging mechanistic targets of LA-rich soybean oils that are linked with reduced liver fat and better cardiometabolic health
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Soybean Oil Foods | Three food product containing 10g of soybean oil each will be consumed each day for a today of 30g of soybean oil consumed each day |
| OTHER | Palm Oil Foods | Three food product containing 10g of palm oil each will be consumed each day for a today of 30g of palm oil consumed each day |
Timeline
- Start date
- 2022-05-02
- Primary completion
- 2025-09-01
- Completion
- 2026-02-01
- First posted
- 2022-01-20
- Last updated
- 2025-12-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05199948. Inclusion in this directory is not an endorsement.